Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newsletter Article
|
![]() |
Press Release: Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial ResultsDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 9, 2024Digital Resources/Online E-Resources |
2 |
Material Type: Newsletter Article
|
![]() |
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial ResultsPR Newswire, 2024Copyright PR Newswire Association LLC May 9, 2024Digital Resources/Online E-Resources |
3 |
Material Type: Newsletter Article
|
![]() |
Cogent Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
4 |
Material Type: Newsletter Article
|
![]() |
Press Release: Cogent Biosciences Reports First Quarter 2024 Financial ResultsDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 7, 2024Digital Resources/Online E-Resources |
5 |
Material Type: Newsletter Article
|
![]() |
Press Release: NextCure Provides Business Update and Reports First Quarter 2024 Financial ResultsDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 2, 2024Digital Resources/Online E-Resources |
6 |
Material Type: Newsletter Article
|
![]() |
NextCure Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
7 |
Material Type: Newsletter Article
|
![]() |
Press Release: Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Mar 1, 2024Digital Resources/Online E-Resources |
8 |
Material Type: Newsletter Article
|
![]() |
Press Release: Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Feb 28, 2024Digital Resources/Online E-Resources |
9 |
Material Type: Newsletter Article
|
![]() |
Press Release: Celcuity Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate UpdatesDow Jones Institutional News, 2023Copyright Dow Jones & Company Inc. Aug 10, 2023Digital Resources/Online E-Resources |
10 |
Material Type: Newsletter Article
|
![]() |
Press Release: Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial ResultsDow Jones Institutional News, 2023Copyright Dow Jones & Company Inc. Aug 8, 2023Digital Resources/Online E-Resources |
11 |
Material Type: Newsletter Article
|
![]() |
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial ResultsNASDAQ OMX's News Release Distribution Channel, 2023GlobeNewswire, Inc.Digital Resources/Online E-Resources |
12 |
Material Type: Newsletter Article
|
![]() |
Press Release: Tempest Reports Second Quarter 2022 Financial Results and Provides Business UpdateDow Jones Institutional News, 2022Copyright Dow Jones & Company Inc. Aug 15, 2022Digital Resources/Online E-Resources |
13 |
Material Type: Newsletter Article
|
![]() |
Lyell Immunopharma Highlights Business Highlights and Financial Results for First Quarter 2024Entertainment Close - Up, 2024Copyright Close-Up Media, Inc. May 21, 2024Digital Resources/Online E-Resources |
14 |
Material Type: Newsletter Article
|
![]() |
Lyell Immunopharma Reports Business Highlights and Financial Results for First Quarter 2024Manufacturing Close - Up, 2024Copyright Close-Up Media, Inc. May 20, 2024Digital Resources/Online E-Resources |
15 |
Material Type: Newsletter Article
|
![]() |
Lyell Immunopharma Reports Business Highlights and Financial Results for First Quarter 2024Wireless News, 2024Copyright Close-Up Media, Inc. May 18, 2024 ;Copyright Close-Up Media, Inc. May 17, 2024Digital Resources/Online E-Resources |
16 |
Material Type: Newsletter Article
|
![]() |
Boundless Bio Reports First Quarter 2024 Financial Results, Corporate HighlightsEntertainment Close - Up, 2024Copyright Close-Up Media, Inc. May 18, 2024 ;Copyright Close-Up Media, Inc. May 17, 2024Digital Resources/Online E-Resources |
17 |
Material Type: Newsletter Article
|
![]() |
Rapt Therapeutics (RAPT: $4.24) jumps 6.0% on robust volume; +24c [6.0%] Vol Index 1.8 [1 is avg]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 16, 2024Digital Resources/Online E-Resources |
18 |
Material Type: Newsletter Article
|
![]() |
Boundless Bio Reports First Quarter 2024 Financial Results, Corporate HighlightsWireless News, 2024Copyright Close-Up Media, Inc. May 16, 2024Digital Resources/Online E-Resources |
19 |
Material Type: Newsletter Article
|
![]() |
Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
20 |
Material Type: Newsletter Article
|
![]() |
Lyell Immunopharma Reports Business Highlights and Financial Results for First Quarter 2024Entertainment Close - Up, 2024Copyright Close-Up Media, Inc. May 15, 2024Digital Resources/Online E-Resources |